Study Stopped
National Institutes of Health terminated funding on March 10, 2025.
Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities
1 other identifier
interventional
200
1 country
2
Brief Summary
While the COVID-19 pandemic has highlighted health disparities, Black children have unduly suffered and died from seasonal influenza for decades. Through sustained partnership with Black community stakeholders, novel community-engaged research methods, and an innovative intervention approach, this proposal will explore, develop, and test a Digital Storytelling intervention to reduce influenza vaccination disparities in Black children aged 6 months to 5 years. This project will advance our understanding of engagement methods and interventions that improve health equity and serve as a model for future work to address vaccination disparities, ensuring all individuals have the chance to fulfill their potential free of preventable diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedStudy Start
First participant enrolled
August 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2025
CompletedMay 14, 2025
January 1, 2024
7 months
January 18, 2024
May 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Child influenza vaccination status at influenza season's end (defined as March 31, 2025 for season 1 and March 31, 2026 for season 2 if a 2nd season of recruitment is necessary)
Binary variable: Vaccinated (if a child received 1 or more doses of influenza vaccine), Unvaccinated (if a child received 0 doses)
Baseline, up to 1 year
Secondary Outcomes (3)
Intervention Feasibility
through study completion, an average of 1 year
Intervention Acceptability
through study completion, an average of 1 year
Intervention Appropriateness
through study completion, an average of 1 year
Study Arms (2)
Digital storytelling group
EXPERIMENTALCaregivers will receive a series of digital stories by text message designed to increase influenza vaccine confidence.
Control group
NO INTERVENTIONCaregivers will receive standard care.
Interventions
Caregivers will receive text messages with embedded digital stories and messaging to encourage influenza vaccination.
Eligibility Criteria
You may qualify if:
- Caregivers of a child who is empaneled at Denver Health (e.g. had 1 well child visit in last 18 months)
- Child will be aged 6 months to 5 years during the influenza season in which the trial will be conducted (season 1: 10/1/24-3/31/25; season 2 (if needed): 10/1/25-3/31/26)
- Child has no medical contraindications to vaccination (e.g., severe allergy to one of the vaccine ingredients, history of Guillan-Barre Syndrome)
You may not qualify if:
- \- Caregivers whose first language is not English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Denver Health Eastside Clinic
Denver, Colorado, 80205, United States
Denver Health Park Hill Clinic
Denver, Colorado, 80207, United States
Related Publications (2)
Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.
PMID: 28851459RESULTWilliams JTB, Kurlandsky K, Stein AB, Bharadwaj N, Hambidge SJ, Pereira RI, O'Leary SC, Johnson D, O'Leary ST. Narrative Reminder Recall to Improve Pediatric Influenza Vaccination: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 2;9(1):e2552149. doi: 10.1001/jamanetworkopen.2025.52149.
PMID: 41493783DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2024
First Posted
February 23, 2024
Study Start
August 2, 2024
Primary Completion
March 10, 2025
Study Completion
March 10, 2025
Last Updated
May 14, 2025
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
Only aggregate data will be shared